nodes	percent_of_prediction	percent_of_DWPC	metapath
Amantadine—DRD2—Gilles de la Tourette syndrome	0.812	1	CbGaD
Amantadine—DDC—Biogenic Amine Synthesis—HDC—Gilles de la Tourette syndrome	0.0131	0.125	CbGpPWpGaD
Amantadine—DRD2—Dopamine receptors—DRD3—Gilles de la Tourette syndrome	0.00471	0.0448	CbGpPWpGaD
Amantadine—DRD2—Dopamine receptors—DRD4—Gilles de la Tourette syndrome	0.00457	0.0435	CbGpPWpGaD
Amantadine—DDC—Nicotine Activity on Dopaminergic Neurons—DRD3—Gilles de la Tourette syndrome	0.00379	0.036	CbGpPWpGaD
Amantadine—DDC—Nicotine Activity on Dopaminergic Neurons—DRD4—Gilles de la Tourette syndrome	0.00368	0.035	CbGpPWpGaD
Amantadine—GRIN1—midbrain—Gilles de la Tourette syndrome	0.00362	0.0439	CbGeAlD
Amantadine—GRIN2C—nervous system—Gilles de la Tourette syndrome	0.0036	0.0436	CbGeAlD
Amantadine—GRIN2C—central nervous system—Gilles de la Tourette syndrome	0.00346	0.042	CbGeAlD
Amantadine—DDC—Nicotine Activity on Dopaminergic Neurons—DRD2—Gilles de la Tourette syndrome	0.00343	0.0326	CbGpPWpGaD
Amantadine—GRIN2C—Hypothetical Network for Drug Addiction—DRD4—Gilles de la Tourette syndrome	0.00339	0.0322	CbGpPWpGaD
Amantadine—SLC22A2—Neurotransmitter Clearance In The Synaptic Cleft—SLC6A3—Gilles de la Tourette syndrome	0.00337	0.0321	CbGpPWpGaD
Amantadine—GRIN2D—nervous system—Gilles de la Tourette syndrome	0.00334	0.0405	CbGeAlD
Amantadine—GRIN2D—central nervous system—Gilles de la Tourette syndrome	0.00322	0.039	CbGeAlD
Amantadine—GRIN2C—Hypothetical Network for Drug Addiction—DRD2—Gilles de la Tourette syndrome	0.00316	0.03	CbGpPWpGaD
Amantadine—GRIN2D—Hypothetical Network for Drug Addiction—DRD4—Gilles de la Tourette syndrome	0.00315	0.03	CbGpPWpGaD
Amantadine—SLC22A1—Neurotransmitter Clearance In The Synaptic Cleft—SLC6A3—Gilles de la Tourette syndrome	0.00314	0.0299	CbGpPWpGaD
Amantadine—GRIN3A—nervous system—Gilles de la Tourette syndrome	0.00314	0.0381	CbGeAlD
Amantadine—GRIN3A—central nervous system—Gilles de la Tourette syndrome	0.00303	0.0367	CbGeAlD
Amantadine—GRIN2A—midbrain—Gilles de la Tourette syndrome	0.00302	0.0366	CbGeAlD
Amantadine—GRIN1—nervous system—Gilles de la Tourette syndrome	0.00298	0.0361	CbGeAlD
Amantadine—GRIN2D—Hypothetical Network for Drug Addiction—DRD2—Gilles de la Tourette syndrome	0.00294	0.0279	CbGpPWpGaD
Amantadine—GRIN1—central nervous system—Gilles de la Tourette syndrome	0.00287	0.0348	CbGeAlD
Amantadine—GRIN2B—nervous system—Gilles de la Tourette syndrome	0.00284	0.0345	CbGeAlD
Amantadine—DDC—midbrain—Gilles de la Tourette syndrome	0.00282	0.0342	CbGeAlD
Amantadine—GRIN2C—brain—Gilles de la Tourette syndrome	0.00275	0.0333	CbGeAlD
Amantadine—GRIN2B—central nervous system—Gilles de la Tourette syndrome	0.00274	0.0332	CbGeAlD
Amantadine—DDC—Dopaminergic Neurogenesis—SLC6A3—Gilles de la Tourette syndrome	0.00262	0.0249	CbGpPWpGaD
Amantadine—GRIN2A—Hypothetical Network for Drug Addiction—DRD4—Gilles de la Tourette syndrome	0.00259	0.0246	CbGpPWpGaD
Amantadine—GRIN2D—brain—Gilles de la Tourette syndrome	0.00256	0.031	CbGeAlD
Amantadine—GRIN2A—nervous system—Gilles de la Tourette syndrome	0.00248	0.0301	CbGeAlD
Amantadine—GRIN2A—Hypothetical Network for Drug Addiction—DRD2—Gilles de la Tourette syndrome	0.00241	0.0229	CbGpPWpGaD
Amantadine—GRIN3A—brain—Gilles de la Tourette syndrome	0.0024	0.0291	CbGeAlD
Amantadine—GRIN2A—central nervous system—Gilles de la Tourette syndrome	0.00239	0.029	CbGeAlD
Amantadine—DDC—nervous system—Gilles de la Tourette syndrome	0.00232	0.0281	CbGeAlD
Amantadine—GRIN1—brain—Gilles de la Tourette syndrome	0.00228	0.0276	CbGeAlD
Amantadine—GRIN1—Hypothetical Network for Drug Addiction—DRD4—Gilles de la Tourette syndrome	0.00226	0.0215	CbGpPWpGaD
Amantadine—DDC—central nervous system—Gilles de la Tourette syndrome	0.00224	0.0271	CbGeAlD
Amantadine—GRIN2B—Hypothetical Network for Drug Addiction—DRD4—Gilles de la Tourette syndrome	0.0022	0.0209	CbGpPWpGaD
Amantadine—GRIN2B—brain—Gilles de la Tourette syndrome	0.00217	0.0263	CbGeAlD
Amantadine—DDC—Parkinsons Disease Pathway—SLC6A3—Gilles de la Tourette syndrome	0.00217	0.0206	CbGpPWpGaD
Amantadine—MAOB—Alpha-synuclein signaling—SLC6A3—Gilles de la Tourette syndrome	0.00215	0.0204	CbGpPWpGaD
Amantadine—GRIN1—Hypothetical Network for Drug Addiction—DRD2—Gilles de la Tourette syndrome	0.0021	0.02	CbGpPWpGaD
Amantadine—GRIN2B—Hypothetical Network for Drug Addiction—DRD2—Gilles de la Tourette syndrome	0.00205	0.0195	CbGpPWpGaD
Amantadine—GRIN2A—brain—Gilles de la Tourette syndrome	0.0019	0.023	CbGeAlD
Amantadine—DDC—brain—Gilles de la Tourette syndrome	0.00177	0.0215	CbGeAlD
Amantadine—DDC—Amino acid and derivative metabolism—HDC—Gilles de la Tourette syndrome	0.00174	0.0165	CbGpPWpGaD
Amantadine—SLC22A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A3—Gilles de la Tourette syndrome	0.00169	0.0161	CbGpPWpGaD
Amantadine—SLC22A1—Na+/Cl- dependent neurotransmitter transporters—SLC6A3—Gilles de la Tourette syndrome	0.00157	0.015	CbGpPWpGaD
Amantadine—SIGMAR1—midbrain—Gilles de la Tourette syndrome	0.00152	0.0184	CbGeAlD
Amantadine—DRD2—Nicotine Activity on Dopaminergic Neurons—DRD3—Gilles de la Tourette syndrome	0.00149	0.0142	CbGpPWpGaD
Amantadine—MAOB—midbrain—Gilles de la Tourette syndrome	0.00145	0.0176	CbGeAlD
Amantadine—DRD2—Nicotine Activity on Dopaminergic Neurons—DRD4—Gilles de la Tourette syndrome	0.00145	0.0138	CbGpPWpGaD
Amantadine—SLC22A1—nervous system—Gilles de la Tourette syndrome	0.00135	0.0164	CbGeAlD
Amantadine—SLC22A1—central nervous system—Gilles de la Tourette syndrome	0.0013	0.0158	CbGeAlD
Amantadine—DRD2—midbrain—Gilles de la Tourette syndrome	0.00123	0.0149	CbGeAlD
Amantadine—DRD2—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00122	0.0116	CbGpPWpGaD
Amantadine—MAOB—nervous system—Gilles de la Tourette syndrome	0.00119	0.0145	CbGeAlD
Amantadine—SLC22A2—Amine compound SLC transporters—SLC6A3—Gilles de la Tourette syndrome	0.00117	0.0111	CbGpPWpGaD
Amantadine—MAOB—central nervous system—Gilles de la Tourette syndrome	0.00115	0.0139	CbGeAlD
Amantadine—SLC22A1—Amine compound SLC transporters—SLC6A3—Gilles de la Tourette syndrome	0.00109	0.0104	CbGpPWpGaD
Amantadine—DRD2—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00104	0.0099	CbGpPWpGaD
Amantadine—DRD2—Hypothetical Network for Drug Addiction—DRD4—Gilles de la Tourette syndrome	0.00104	0.00985	CbGpPWpGaD
Amantadine—SLC22A1—brain—Gilles de la Tourette syndrome	0.00103	0.0125	CbGeAlD
Amantadine—DRD2—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00101	0.00961	CbGpPWpGaD
Amantadine—DRD2—nervous system—Gilles de la Tourette syndrome	0.00101	0.0122	CbGeAlD
Amantadine—DRD2—central nervous system—Gilles de la Tourette syndrome	0.00097	0.0118	CbGeAlD
Amantadine—SIGMAR1—brain—Gilles de la Tourette syndrome	0.000954	0.0116	CbGeAlD
Amantadine—MAOB—brain—Gilles de la Tourette syndrome	0.000913	0.0111	CbGeAlD
Amantadine—DRD2—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.000875	0.00832	CbGpPWpGaD
Amantadine—DRD2—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00085	0.00808	CbGpPWpGaD
Amantadine—DRD2—brain—Gilles de la Tourette syndrome	0.00077	0.00934	CbGeAlD
Amantadine—GRIN2C—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.000742	0.00705	CbGpPWpGaD
Amantadine—GRIN2D—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.00069	0.00656	CbGpPWpGaD
Amantadine—DRD2—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00066	0.00627	CbGpPWpGaD
Amantadine—DDC—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.000622	0.00592	CbGpPWpGaD
Amantadine—DDC—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.000604	0.00574	CbGpPWpGaD
Amantadine—GRIN2C—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.000569	0.0054	CbGpPWpGaD
Amantadine—GRIN2A—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.000567	0.00539	CbGpPWpGaD
Amantadine—DDC—Circadian rythm related genes—DRD2—Gilles de la Tourette syndrome	0.000563	0.00535	CbGpPWpGaD
Amantadine—DRD2—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000554	0.00527	CbGpPWpGaD
Amantadine—ABCB1—midbrain—Gilles de la Tourette syndrome	0.00053	0.00642	CbGeAlD
Amantadine—GRIN2D—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.000529	0.00502	CbGpPWpGaD
Amantadine—GRIN1—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.000494	0.0047	CbGpPWpGaD
Amantadine—DDC—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.000483	0.00459	CbGpPWpGaD
Amantadine—GRIN2B—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.000482	0.00458	CbGpPWpGaD
Amantadine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—Gilles de la Tourette syndrome	0.000458	0.00436	CbGpPWpGaD
Amantadine—ABCB1—nervous system—Gilles de la Tourette syndrome	0.000436	0.00528	CbGeAlD
Amantadine—GRIN2A—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.000434	0.00413	CbGpPWpGaD
Amantadine—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—Gilles de la Tourette syndrome	0.000427	0.00406	CbGpPWpGaD
Amantadine—ABCB1—central nervous system—Gilles de la Tourette syndrome	0.000419	0.00508	CbGeAlD
Amantadine—GRIN1—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.000415	0.00394	CbGpPWpGaD
Amantadine—GRIN1—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.000379	0.0036	CbGpPWpGaD
Amantadine—GRIN2B—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.000369	0.00351	CbGpPWpGaD
Amantadine—ABCB1—brain—Gilles de la Tourette syndrome	0.000333	0.00404	CbGeAlD
Amantadine—DDC—Metabolism—HDC—Gilles de la Tourette syndrome	0.000319	0.00303	CbGpPWpGaD
Amantadine—MAOB—Metabolism—HDC—Gilles de la Tourette syndrome	0.000268	0.00255	CbGpPWpGaD
Amantadine—SLC22A2—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.000257	0.00244	CbGpPWpGaD
Amantadine—DRD2—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.000245	0.00233	CbGpPWpGaD
Amantadine—SLC22A1—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.000239	0.00228	CbGpPWpGaD
Amantadine—DRD2—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.000238	0.00226	CbGpPWpGaD
Amantadine—DRD2—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.000217	0.00206	CbGpPWpGaD
Amantadine—DRD2—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00021	0.002	CbGpPWpGaD
Amantadine—SLC22A2—SLC-mediated transmembrane transport—SLC6A3—Gilles de la Tourette syndrome	0.000208	0.00198	CbGpPWpGaD
Amantadine—GRIN1—Axon guidance—MET—Gilles de la Tourette syndrome	0.000206	0.00196	CbGpPWpGaD
Amantadine—DRD2—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000201	0.00191	CbGpPWpGaD
Amantadine—GRIN2B—Axon guidance—MET—Gilles de la Tourette syndrome	0.000201	0.00191	CbGpPWpGaD
Amantadine—SLC22A2—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.000197	0.00187	CbGpPWpGaD
Amantadine—DRD2—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000195	0.00185	CbGpPWpGaD
Amantadine—SLC22A1—SLC-mediated transmembrane transport—SLC6A3—Gilles de la Tourette syndrome	0.000194	0.00185	CbGpPWpGaD
Amantadine—SLC22A1—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.000183	0.00174	CbGpPWpGaD
Amantadine—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000172	0.00164	CbGpPWpGaD
Amantadine—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000167	0.00159	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—MET—Gilles de la Tourette syndrome	0.000147	0.0014	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—MET—Gilles de la Tourette syndrome	0.000143	0.00136	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—HDC—Gilles de la Tourette syndrome	0.000142	0.00135	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—HDC—Gilles de la Tourette syndrome	0.000133	0.00126	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000131	0.00125	CbGpPWpGaD
Amantadine—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000127	0.00121	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000127	0.00121	CbGpPWpGaD
Amantadine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000109	0.00104	CbGpPWpGaD
Amantadine—SLC22A2—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.000106	0.00101	CbGpPWpGaD
Amantadine—SLC22A1—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	9.86e-05	0.000938	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	8.3e-05	0.000789	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—HDC—Gilles de la Tourette syndrome	7.78e-05	0.00074	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	7.41e-05	0.000704	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	7.19e-05	0.000684	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	6.73e-05	0.00064	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	6.53e-05	0.000621	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	5.78e-05	0.00055	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	4.69e-05	0.000446	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	4.26e-05	0.000405	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.97e-05	0.000378	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.86e-05	0.000367	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.52e-05	0.000239	CbGpPWpGaD
